PMP/Appendiceal Cancer Seminar
Saturday, April 6, 2019
7:30 AM-12:30 PM
Drexel University College of Medicine and Hahnemann University Hospital are hosting a CME/CE Seminar featuring nationally recognized experts in the field of surgical oncology. Registration and parking are complimentary. Continental breakfast and lunch buffets will be provided.
Register for this event
Innovations in the Multidisciplinary Management of PMP/Appendiceal Cancer
Jesus Esquivel, MD, FACS, surgical oncologist, Frederick Regional Health System
Paul H. Sugarbaker, MD, FACS, FRCS, director, Center for Gastrointestinal Malignancies, Washington Cancer Institute
Wilbur B. Bowne, MD, FACS, professor of surgery
- Discuss current role of CT and MRI in the radiographic evaluation of newly diagnosed
or recurrent PMP/appendiceal cancer. Which modality of imaging more accurately
determines amount of disease and/or peritoneal carcinomatosis index (PCI)?
- Describe the role of modern expanded molecular profiling/next generation sequencing
to determine optimal chemotherapeutic agents to employ in the neoadjuvant and
adjuvant settings to treat PMP/appendiceal cancer.
- Explain the role of and advances in intraperitoneal immunotherapy for the treatment of
- Analyze the status of clinical trials utilizing CRS and HIPEC for PMP/appendiceal cancer.
- Emphasize the need for standardization of a common pathological classification for
- Assess the requirements to standardize a multidisciplinary treatment approach to
optimize patient outcomes.
This symposium is geared toward:
- Medical oncologists
- Surgical oncologists
- General surgeons
- Physician assistants
- Nurse practitioners and nurses
- Fellows, residents and students
This activity has been planned and
implemented in accordance with the accreditation requirements and policies of
the Accreditation Council for Continuing Medical Education (ACCME) through
the joint providership of Drexel University College of Medicine and Hahnemann
University Hospital. The Drexel University College of Medicine is accredited by
the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement: Drexel University College of
Medicine designates this live activity for a maximum of 4.0 AMA PRA Category
1 Credit(s)™. Physicians should claim only the credit commensurate with the
extent of their participation in the activity.
AOA: This program is eligible for 4.0 credits in Category 2A of the American
PSNA: Hahnemann University Hospital is an approved provider of continuing
nursing education by the Pennsylvania State Nurses Association, an accredited
approver by the American Nurses Credentialing Center's Commission on
Accreditation; 4.0 contact hours will be awarded for attending the entire
Faculty Disclosure Statement
It is the policy of Drexel University
College of Medicine to ensure balance, independence, objectivity, and
scientific rigor in all its sponsored educational programs. Speakers
at continuing medical education activities are required to disclose to
the audience, any relevant commercial interest (which is any entity
producing, marketing, re-selling, or distributing health care goods or
services consumed by, or used on, patients). Any conflicts of interest
must be resolved prior to the presentation and announced to the
audience. The intent of this disclosure is to allow participants to form
their own judgments about the educational content of this activity and
determine whether the speaker’s commercial interests influenced the
presentation. In addition, speakers are required to openly disclose
any off-label, experimental, or investigational use of drugs or devices
discussed in their presentation.
We are pleased to acknowledge an educational
grant from the ACPMP Research Foundation. Additional support will
be acknowledged prior to the beginning of the activity.
Please contact Melissa Coleman,
267.438.5505, or Kimberly Viola,
email@example.com or 215.762.1647 for more information.